Drawing for MY INTEREST IS LIFE

USPTO serial 77339867

MY INTEREST IS LIFE

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
MANOR, THOMAS M
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with MY INTEREST IS LIFE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
001Chemical preparations, namely, biologically compatible chemical substances for scientific, laboratory, clinical and medical research; biological tissue, namely, mammalian soft and hard tissues comprising or derived from stem cells or progenitor cells for scientific, laboratory, clinical and medical research; therapeutic tissue, namely, therapeutic tissue comprising or derived from stem cells or progenitor cells, and compositions comprising or derived from the therapeutic tissues for scientific, laboratory, clinical and medical researchACTIVE—
005Preparations comprising living cells and non-synthetic cellular solids and fluids for placement on or into the mammalian body, for the treatment of disorders, diseases and injuries and for cosmetic reconstructive surgery; biological implants, namely, biological implants comprising or derived from stem cells or progenitor cells; surgical implants, namely, surgical implants comprising living tissue; implantable, injectable and other biological-use preparations comprising or derived from stem cells or progenitor cells for medical purposes; chemicals and chemical preparations and reagents comprising non-synthetic cellular compositions for medical purposes; therapeutic tissue, cellular and stem cell compositions for placement on or into the mammalian body for medical use; tissue, cell and stem cell compositions for placement on or into the mammalian body for cosmetic reconstructive surgery and for the treatment of other human conditions and diseases; Chemical reagents for medical purposes for placement into contact with the mammalian body for the diagnosis of disorders, diseases and injuriesACTIVE—
010Medical apparatus, instruments and articles, namely, medical instruments for processing, concentrating, and implanting cells and cellular compositions; surgical implants comprising non-living tissues and non-living tissue regenerative products for the treatment of cosmetic and other human conditions and diseases; medical instruments for tissue, cell, cellular component and stem cell extraction, processing and application; tissue and cell separation and purification devices, namely, devices used for the isolation of cells and cellular components within adipose tissue for medical use; tissue and cell processing devices, namely, devices used for the collection and storage of adipose tissue and adipose tissue derived cells for medical use; bone and soft tissue implants comprising non-living materials, namely, porous and non-porous sheets of material, porous and non-porous sheets of resorbable material, porous and non-porous sheets of flexible resorbable material, and porous and non-porous scaffolds and cell containment devices for use in repairing various portions of the mammalian skeletal system and other organ systems; medical devices for positioning and securing the bone and soft tissue implantsACTIVE—
039Transport, transport packaging and storage of goods for scientific and medical purposes; storage of tissue, cells and cellular components for scientific and medical purposes; storage of human tissue, cells and cellular components for use in cell and cellular component transplantations and treatments; archival storage services for scientific and medical purposes; electronic storage of biological data; physical storage of biomedical research and biological materialsACTIVE—
044Medical services, namely, hygienic and cosmetic services for human beings or animals; medical services provided by the members of professions such as medical doctors and surgeons and related entities for the analysis and treatment of cosmetic and other human conditions and diseases; medical treatment and medical services using tissue, cells, cellular components and stem cells for cosmetic purposes and the treatment of disorders, diseases and injuriesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (ARAA): This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.

DateCodeEventWhat it means
May 16, 2012ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 16, 2012REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Apr 1, 2011ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 1, 2011REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Oct 13, 2009MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Oct 12, 2009ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Mar 10, 2009NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Dec 16, 2008PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 26, 2008NPUBNOTICE OF PUBLICATION—
Nov 13, 2008PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Nov 12, 2008ALIEASSIGNED TO LIE—
Nov 10, 2008CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 10, 2008XAECEXAMINER'S AMENDMENT ENTERED—
Nov 10, 2008GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Nov 10, 2008GNEAEXAMINERS AMENDMENT E-MAILED—
Nov 10, 2008CNEAEXAMINERS AMENDMENT -WRITTEN—
Oct 20, 2008DOCKASSIGNED TO EXAMINER—
Oct 20, 2008ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Oct 6, 2008PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Sep 23, 2008PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Sep 19, 2008CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 16, 2008XAECEXAMINER'S AMENDMENT ENTERED—
Sep 16, 2008GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Sep 16, 2008GNEAEXAMINERS AMENDMENT E-MAILED—
Sep 16, 2008CNEAEXAMINERS AMENDMENT -WRITTEN—
Aug 19, 2008TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 19, 2008CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 19, 2008TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 24, 2008CEPECOMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION ENTERED—
Apr 23, 2008GEANNOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED—
Apr 23, 2008GEAPEXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED—
Apr 23, 2008CPEAEXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED—
Apr 23, 2008DOCKASSIGNED TO EXAMINER—
Apr 23, 2008ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Apr 4, 2008PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Mar 27, 2008PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Mar 25, 2008ALIEASSIGNED TO LIE—
Mar 11, 2008CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 11, 2008DOCKASSIGNED TO EXAMINER—
Dec 4, 2007NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance